Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ALT — Altimmune, Inc.

CIK 1423053 MIAMI, FL
Back to ALT Full portfolio

Position in ALT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,990,018
+$1,607,490 QoQ
Shares Held
983,559
+119.1% QoQ
Ownership
0.506%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALT Over Time

Shares Held

Position Value (USD)

Derivatives in ALT

reported options exposure · as of Jun 30, 2026
CallValue
$1,918,240
CallShares
631,000
PutValue
$389,120
PutShares
128,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,175,465,875 across 436 Biotechnology names. ALT ranks #177 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in ALT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,990,018 983,559
2026-06-30 $1,918,240 631,000
2026-06-30 $389,120 128,000
2026-03-31 $1,040,732 337,900
2026-03-31 $1,382,528 448,873
2026-03-31 $602,448 195,600
2025-12-31 $2,088,385 578,500
2025-12-31 $1,527,752 423,200
2025-12-31 $4,829,915 1,337,927
2025-09-30 $1,382,836 366,800
2025-09-30 $1,393,769 369,700
2025-09-30 $4,833,192 1,282,014
2025-06-30 $3,430,368 886,400
2025-06-30 $1,008,909 260,700
2025-06-30 $2,025,794 523,461
2025-03-31 $1,262,000 252,400
2025-03-31 $1,581,500 316,300
2024-12-31 $2,601,368 360,800
2024-12-31 $4,867,066 675,044
2024-12-31 $1,761,403 244,300
2024-09-30 $2,625,384 427,587
2024-09-30 $1,326,240 216,000
2024-09-30 $1,876,998 305,700
2024-06-30 $6,789 1,021
2024-06-30 $1,770,895 266,300
2024-06-30 $975,555 146,700
2024-03-31 $3,213,826 315,700
2024-03-31 $774,361 76,067
2024-03-31 $2,537,874 249,300
2023-12-31 $3,188,250 283,400
2023-12-31 $2,751,750 244,600
2023-09-30 $310,450 119,404
2023-09-30 $308,880 118,800
2023-09-30 $299,780 115,300
2023-06-30 $1,167,825 330,829
2023-06-30 $365,355 103,500
2023-06-30 $298,638 84,600
2023-03-31 $1,157,124 274,200
2023-03-31 $8,627,726 2,044,485
2023-03-31 $1,124,630 266,500
2022-12-31 $1,552,880 94,400
2022-12-31 $19,073,133 1,159,461
2022-12-31 $2,967,580 180,400
2022-09-30 $3,596,032 281,600
2022-09-30 $3,166,960 248,000
2022-09-30 $1,650,535 129,251
2022-06-30 $2,077,920 177,600
2022-06-30 $326,430 27,900
2022-06-30 $13,429,937 1,147,858
2022-03-31 $731,409 120,100

Report a Problem

Category
Description
Email (optional, for follow-up)